Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Role of Exosomes in Ischemic Stroke Treatment. | Biomolecules | 2022 | 35053263 | PubTator, text mining | PubMed |
| Neutral sphingomyelinase 2 controls exosome secretion by counteracting V-ATPase-mediated endosome acidification. | J Cell Sci | 2022 | 35050379 | PubTator, text mining | PubMed |
| Exosomes and COVID-19: challenges and opportunities. | Comp Clin Path | 2022 | 35039753 | PubTator, text mining | PubMed |
| Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. | Mol Cancer | 2022 | 35039054 | PubTator, text mining | PubMed |
| Exocyst controls exosome biogenesis via Rab11a. | Mol Ther Nucleic Acids | 2022 | 35036064 | PubTator, text mining | PubMed |
| Potential Application of Exosomes in Vaccine Development and Delivery. | Pharm Res | 2022 | 35028802 | PubTator, text mining | PubMed |
| A specialized multi-disciplinary care program for children with sepsis and multiple organ dysfunction-associated immune dysregulation. | Pediatr Res | 2022 | 35022559 | PubTator, text mining | PubMed |
| Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement. | Ital J Pediatr | 2022 | 35022088 | PubTator, text mining | PubMed |
| Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors. | Clin Exp Immunol | 2022 | 35020865 | PubTator, text mining | PubMed |
| Future of Therapy for Inborn Errors of Immunity. | Clin Rev Allergy Immunol | 2022 | 35020169 | PubTator, text mining | PubMed |
| Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression. | Gut | 2022 | 35012996 | PubTator, text mining | PubMed |
| Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells. | Int J Mol Sci | 2022 | 35008958 | PubTator, text mining | PubMed |
| Secretory Autophagy Forges a Therapy Resistant Microenvironment in Melanoma. | Cancers (Basel) | 2022 | 35008395 | PubTator, text mining | PubMed |
| Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia. | Blood Adv | 2022 | 34991157 | PubTator, text mining | PubMed |
| Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. | J Mol Biol | 2022 | 34990653 | PubTator, text mining | PubMed |
| The emerging roles of exosomal long non-coding RNAs in bladder cancer. | J Cell Mol Med | 2022 | 34981655 | PubTator, text mining | PubMed |
| Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. | Cell Commun Signal | 2022 | 34980146 | PubTator, text mining | PubMed |
| Underappreciated roles for Rho GDP dissociation inhibitors (RhoGDIs) in cell function: Lessons learned from the pancreatic islet β-cell. | Biochem Pharmacol | 2022 | 34968495 | PubTator, text mining | PubMed |
| Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD-L1. | Adv Sci (Weinh) | 2022 | 34927389 | PubTator, text mining | PubMed |
| The First Korean Case of Griscelli Syndrome Type 2 With Hemophagocytic Lymphohistiocytosis and Partial Albinism. | Ann Lab Med | 2022 | 34907113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=53